Noelia Moncada-Puente

Oviedo, AS, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes.

The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes.

Journal: Nature communications

Published: April 10, 2025

Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia.

Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia.

Journal: Nature cancer

Published: January 19, 2024

FLT3-ITD regulation of the endoplasmic reticulum functions in acute myeloid leukemia.

FLT3-ITD regulation of the endoplasmic reticulum functions in acute myeloid leukemia.

Journal: Hematological oncology

Published: January 12, 2024

Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases.

Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases.

Journal: Blood

Published: July 10, 2023

Endoplasmic reticulum regulation of glucose metabolism in glioma stem cells.

Endoplasmic reticulum regulation of glucose metabolism in glioma stem cells.

Journal: International journal of oncology

Published: April 27, 2023

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.

Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity.

Journal: Blood advances

Published: February 09, 2023

Calcium acts as a central player in melatonin antitumor activity in sarcoma cells.

Calcium acts as a central player in melatonin antitumor activity in sarcoma cells.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: April 08, 2022

The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML.

The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML.

Journal: Blood advances

Published: March 25, 2022

Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration.

Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration.

Journal: Journal of cellular physiology

Published: January 30, 2020

Role of glucose metabolism in the differential antileukemic effect of melatonin on wild‑type and FLT3‑ITD mutant cells.

Role of glucose metabolism in the differential antileukemic effect of melatonin on wild‑type and FLT3‑ITD mutant cells.

Journal: Oncology reports

Published: November 05, 2019

Inhibition of FLT3 and PIM Kinases by EC-70124 Exerts Potent Activity in Preclinical Models of Acute Myeloid Leukemia.

Inhibition of FLT3 and PIM Kinases by EC-70124 Exerts Potent Activity in Preclinical Models of Acute Myeloid Leukemia.

Journal: Molecular cancer therapeutics

Published: June 19, 2017

Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin.

Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin.

Journal: Molecular and cellular endocrinology

Published: March 29, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026